SunirJoshiMD

PubMed

• 1 citations
  Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
  David M Brown, David S Boyer, Diana V Do, Charles C Wykoff, Taiji Sakamoto, Peter Win, Sunir Joshi, Hani Salehi-Had, András Seres, Alyson J Berliner, Sergio Leal, Robe...> ;Lancet. 2024 Mar 23
• 3 citations
  Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial.
  Mark R Barakat, Michael S Ip, Charles C Wykoff, David A Eichenbaum, Sunir Joshi, David Warrow, Veeral S Sheth, Jana Stefanickova, Yong Soo Kim, Fanyin He, Ga Eun Cho, ...> ;JAMA Ophthalmology. 2023 Dec 1
• 5 citations
  Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration.
  Anny M Cheng, Sunir Joshi, Raphael G Banoub, Kakarla V Chalam, Saddemi, J.> ;Cureus. 2023 Jun 1
• Reply to Comment on: A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis.
  Christopher N. Ta, Michael B. Raizman, Robert D. Gross, Sunir Joshi, Sushanta Mallick, Yuemei Wang, Bruce Segal> ;American Journal of Ophthalmology. 2020 Aug 18
• 4 citations
  A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis
  Christopher N. Ta, Michael B. Raizman, Robert D. Gross, Sunir Joshi, Sushanta Mallick, Yuemei Wang, Bruce Segal> ;American Journal of Ophthalmology. 2020 Mar 25
• Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments.
  Joshi, S. G.,Elias, M.,Singh, A.,Al-Saleem, F. H.,Ancharski, D.,Nasser, Z.,Takahashi, T.,Simpson, L. L.> ;Neuroscience. 2011 Feb 01
• Join now to see all